We're speeding up cancer discoveries & reducing barriers with $50M in grants to Dana-Farber @HopkinsKimmel, Memorial Sloan Kettering Cancer Center, Koch Institute at MIT, & MD Anderson Cancer Center to find cures for some of the deadliest cancers. Learn more: bit.ly/3vPtU0G #breakthroughcancer

“it is difficult to predict where breakthroughs in medicine will come from, but one certainty is investments in education, training, and basic-science–driven discovery often reap dividends far beyond original cost, enabling chance to favor prepared mind” journals.plos.org/plospathogens/…

So exited to meet with other V-scholars and discuss cool science we are doing!@TheVFoundation

Fun fact! The name Ki67 derived from the city of Kiel (Ki) where the antibody was produced in the university department of pathology and refers to the number of the original clone (67). #Ki67

Following a promising first year of our 2022–27 strategic plan, we’re increasing our investment in programs to advance the study and treatment of pediatric cancer and other catastrophic diseases. Learn more. ow.ly/f1sU50JUXAR #StJudeResearch

Findings from St. Jude scientists have revealed a new therapeutic target for an aggressive type of rhabdomyosarcoma. ow.ly/LTXo50JVYpp Science Translational Medicine #childhoodcancer

The most amazing science paper you can read this year! Synthetic embryos grown ex-utero (no sperm/no eggs/no utero needed) - the scientific basis for renewal.bio - the company me and Jacob (Yaqub) Hanna - يعقوب حنا just started! cell.com/cell/fulltext/…

So true!

We now welcome proteolysis-targeting antibodies (PROTABs) as degraders of cell surface receptors. nature nature.com/articles/s4158…

Do you know an early-career scientist or trainee with an interest in childhood cancer survivorship research? Apply by Tuesday, November 1, for the Childhood Cancer Survivor Study Career Development Award. Learn more. bit.ly/3epILbs #CCAM #CancerResearch

“It is exciting & gratifying that investigations into hemoglobin & globin gene expression continue to produce new, clinically relevant discoveries,” Dr. Mitch Weiss says. Discover implications for sickle cell disease, published in nature. bit.ly/3yvdFpZ Ruopeng Feng

Thrilled to share my primary PhD work: a Transcription Factor Atlas for understanding gene regulation and cell engineering Cell. We created a comprehensive TF ORF library and applied it to profile resulting expression changes. A thread 1/X sciencedirect.com/science/articl…

Malignant Progression of an Ancestral Bone Marrow Clone Harboring a CIC-NUTM2A Fusion in Isolated Myeloid Sarcoma aacrjournals.org/mcr/article-ab…

Check out our recent paper using advanced auxin inducible degron (AID2) and mutant reconstruction cellular system to study transcriptional impact of CTCF.

O’Neal Cancer Center Associate Scientist Rui Lu, Ph.D., has been named a 2023 James A. Pittman Jr., M.D., Scholar. The Pittman Scholars program recognizes the astounding research achievements and discoveries of junior faculty at UAB Heersink School of Medicine. 🔗: uab.edu/medicine/news/…

Bottom Line: Sustained support from Congress allows National Cancer Institute to raise paylines for R01 and ESI grants. As a result, in FY 2023, NCI expects to issue more than 100 additional R01 and ESI awards than last year. cancer.gov/grants-trainin…

Inspired by nature, sourced from nature, designed for nature, and published in nature ! Biodegradable morphing robots are "gone to earth".

A big shoutout for Shaela, Jianzhong and Hong to lead this study. Thanks to all fantastic collaborators, especially our own Jun Yang for carrying out in vivo work. Cannot thank more for funding support. ACS Research The V Foundation for Cancer Research St. Jude Research

So excited to receive the promotion notice to Associate Member on such a beautiful Monday morning! My department chair was Cc’ed and today is also his birthday. Also, 14 years ago today, I completed my Ph.D defense. Thank you for everyone I met during this journey.